Deans' stroke musings: Clinical therapeutic guideline for neurorestoration in spinal cord injury (Chinese version 2016)

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, April 5, 2017

Clinical therapeutic guideline for neurorestoration in spinal cord injury (Chinese version 2016)

Look at that, something close to a protocol for spinal cord injury and we have zilch for protocols for stroke recovery. What a fucking pile of crap our stroke medical professionals have for us. ABSOLUTELY NOTHING!!!
https://www.dovepress.com/articles.php?article_id=32204

Authors Feng YP, Sun TS, Chen L, Xie JX, Zhang ZC, Huang HY, He XJ
Received 12 August 2016
Accepted for publication 29 September 2016
Published 3 April 2017 Volume 2017:5 Pages 73—83
DOI https://doi.org/10.2147/JN.S119581
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Hari Shanker Sharma

Yaping Feng,^1,* Tiansheng Sun,^2,* Lin Chen,³ Jiaxin Xie,¹ Zhicheng Zhang,² Hongyun Huang,⁴ Xijing He⁵

On behalf of the Chinese Association of Neurorestoratology and Chinese Branch of the International Association of Neurorestoratology

¹Department of Neurosurgery, Kunming General Hospital of People’s Liberation Army (Spinal Cord Injury Treatment Center of People’s Liberation Army), Kunming, Yunnan, ²Department of Orthopedics, Beijing Army General Hospital, ³Department of Neurosurgery, Yuquan Hospital, Tsinghua University, ⁴Institute of Neurorestoratology, General Hospital of Armed Police Forces, Beijing, ⁵Department of Orthopedics, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaaxi, China

^*These authors contributed equally to this work

Abstract: Restoring functions following spinal cord injury (SCI) was the most challenging task in clinical practice in the past. Fortunately, some effective neurorestorative methods have been exploited in acute, subacute, and chronic phase of SCI. There were no clinical neurorestorative therapeutic guidelines available before this document which can be followed by physicians to manage patients with acute, subacute, and chronic SCI. This guideline will be a helpful reference to physicians to implement their neurorestorative strategies that can help to improve the neurological functions in patients with SCI and their quality of life.

Keywords: clinical therapeutic guideline, neurorestorative strategies, spinal cord injury, cell therapy, cordotomy, neurotization

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]